149 related articles for article (PubMed ID: 37726993)
1. [The safety and efficacy of prophylactic hyperthermic intraperitoneal chemotherapy for elderly patients with locally advanced gastric cancer: a propensity score matching analysis].
Yu T; Ma FH; An Q; Cao XL; Xiao G; Wu GJ
Zhonghua Yi Xue Za Zhi; 2023 Sep; 103(36):2867-2873. PubMed ID: 37726993
[No Abstract] [Full Text] [Related]
2. Prognostic Analysis of Prophylactic Hyperthermic Intraperitoneal Chemotherapy for Advanced Gastric Cancer: a Propensity Score-Matched Analysis.
Liu L; Zheng L; Liu S; Zhang M; Zhang S; Jiang Z; Qin C; Wang D
J Gastrointest Surg; 2023 Nov; 27(11):2297-2307. PubMed ID: 37715013
[TBL] [Abstract][Full Text] [Related]
3. [Safety evaluation of hyperthermic intraperitoneal chemotherapy in patients with local advanced gastric cancer after radical resection for prevention of peritoneal metastasis].
Lin Y; Shen C; Guo XK; Li Y; Wang DD; Chen X; Wang Z; Wu K; Tao KX; Wu CQ
Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Jan; 25(1):48-55. PubMed ID: 35067034
[No Abstract] [Full Text] [Related]
4. Phase II trial of prophylactic hyperthermic intraperitoneal chemotherapy in patients with locally advanced gastric cancer after curative surgery.
Fan B; Bu Z; Zhang J; Zong X; Ji X; Fu T; Jia Z; Zhang Y; Wu X
BMC Cancer; 2021 Mar; 21(1):216. PubMed ID: 33653317
[TBL] [Abstract][Full Text] [Related]
5. Prophylactic hyperthermic intraperitoneal chemotherapy for patients with clinical T4 gastric cancer.
Lee TY; Hsu CH; Fan HL; Liao GS; Chen TW; Chan DC
Eur J Surg Oncol; 2022 Sep; 48(9):1972-1979. PubMed ID: 35508455
[TBL] [Abstract][Full Text] [Related]
6. [Safety of patients undergoing radical resection combined with paclitaxel-based hyperthermic intraperitoneal chemotherapy for locally advanced gastric cancer].
Mei JX; Zhao LY; Zhang WH; Liu K; Chen XL; Yang K; Hu JK
Zhonghua Wei Chang Wai Ke Za Zhi; 2024 May; 27(5):471-477. PubMed ID: 38778687
[No Abstract] [Full Text] [Related]
7. Comparative Study of the Efficacy and Safety of Radical Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy in Locally Advanced Gastric Cancer: A Propensity Score-Matching Analysis.
Shen C; Lin Y; Guo X; Li Y; Wang D; Du Z; Hu P; Chen X; Zeng X; Lv J; Wu C; Tao K
Ann Surg Oncol; 2022 Dec; 29(13):8551-8563. PubMed ID: 35941344
[TBL] [Abstract][Full Text] [Related]
8. Morbidity following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal metastases with or without early postoperative intraperitoneal chemotherapy: A propensity score matched study.
Dranichnikov P; Graf W; Cashin PH
Eur J Surg Oncol; 2022 Jul; 48(7):1598-1605. PubMed ID: 35177313
[TBL] [Abstract][Full Text] [Related]
9. Hyperthermic intraperitoneal chemotherapy (HIPEC) plus systemic chemotherapy versus systemic chemotherapy alone in locally advanced gastric cancer after D2 radical resection: a randomized-controlled study.
Yu P; Huang X; Huang L; Dai G; Xu Q; Fang J; Ye Z; Chai T; Du Y
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11491-11498. PubMed ID: 37392201
[TBL] [Abstract][Full Text] [Related]
10. Prophylactic HIPEC with radical D2 gastrectomy improves survival and peritoneal recurrence rates for locally advanced gastric cancer: personal experience from a randomized case control study.
Beeharry MK; Zhu ZL; Liu WT; Yao XX; Yan M; Zhu ZG
BMC Cancer; 2019 Sep; 19(1):932. PubMed ID: 31533660
[TBL] [Abstract][Full Text] [Related]
11. Does hipec improve outcomes in gastric cancer patients treated with perioperative chemotherapy and radical surgery? A propensity-score matched analysis.
Diniz TP; da Costa WL; Fonseca de Jesus VH; Ribeiro HSC; Diniz AL; de Godoy AL; de Farias IC; Torres SM; Felismino TC; Coimbra FJF
J Surg Oncol; 2020 Apr; 121(5):823-832. PubMed ID: 31950511
[TBL] [Abstract][Full Text] [Related]
12. Perioperative outcomes and survival in elderly patients aged ≥ 75 years undergoing gastrectomy for gastric cancer: an 18-year retrospective analysis in a single Western centre.
Tan E; Lam S; Han SP; Storey D; Sandroussi C
Langenbecks Arch Surg; 2021 Jun; 406(4):1057-1069. PubMed ID: 33770264
[TBL] [Abstract][Full Text] [Related]
13. [Efficacy of 1 384 cases of peritoneal carcinomatosis underwent cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy].
Yu Y; Li XB; Lin YL; Ma R; Ji ZH; Zhang YB; An SL; Liu G; Yang XJ; Li Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Mar; 24(3):230-239. PubMed ID: 34645167
[No Abstract] [Full Text] [Related]
14. Intraoperative hyperthermic intraperitoneal chemotherapy as adjuvant chemotherapy for advanced gastric cancer patients with serosal invasion.
Kang LY; Mok KT; Liu SI; Tsai CC; Wang BW; Chen IS; Chen YC; Chang BM; Chou NH
J Chin Med Assoc; 2013 Aug; 76(8):425-31. PubMed ID: 23796652
[TBL] [Abstract][Full Text] [Related]
15. Role of prophylactic hyperthermic intraperitoneal chemotherapy in patients with locally advanced gastric cancer.
Xie TY; Wu D; Li S; Qiu ZY; Song QY; Guan D; Wang LP; Li XG; Duan F; Wang XX
World J Gastrointest Oncol; 2020 Jul; 12(7):782-790. PubMed ID: 32864045
[TBL] [Abstract][Full Text] [Related]
16. A novel method of bedside hyperthermic intraperitoneal chemotherapy as adjuvant therapy for stage-III gastric cancer.
Liu L; Sun L; Zhang N; Liao CG; Su H; Min J; Song Y; Yang X; Huang X; Chen D; Chen Y; Zhang HW; Zhang H
Int J Hyperthermia; 2022; 39(1):239-245. PubMed ID: 35100917
[TBL] [Abstract][Full Text] [Related]
17. Combined Prophylactic Hyperthermic Intraperitoneal Chemotherapy and Intraoperative Radiotherapy for Localized Gastroesophageal Junction and Gastric Cancer: A Comparative Nonrandomized Study.
Bazarbashi S; Badran A; Gad AM; Aljubran A; Alzahrani A; Alshibani A; Alrakaf R; Elhassan T; Alsuhaibani A; Elshenawy MA
Ann Surg Oncol; 2023 Jan; 30(1):426-432. PubMed ID: 36042103
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the outcomes of cytoreductive surgery versus surgery plus hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis: a propensity score matching analysis.
Li Z; Redondo Ntutumu JD; Huang S; Cai Z; Han S; Balde AI; Luo Z; Fang S
Surg Endosc; 2021 Jun; 35(6):2789-2796. PubMed ID: 32632486
[TBL] [Abstract][Full Text] [Related]
19. [Short-term outcomes and long-term quality of life after undergoing radical proximal gastrectomy with esophageal gastric tube anastomosis and total gastrectomy with Roux-en-Y anastomosis for Siewert type II and III adenocarcinoma of the esophagogastric junction: A propensity score matching analysis].
Xu ZW; Zhao K; Hong QQ; Chen YF; Wang HB; Lin HX; Wang TH; Xiao LB; Zhu JT; Yan S; You J
Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Feb; 26(2):181-190. PubMed ID: 36797565
[No Abstract] [Full Text] [Related]
20. Survival advantage of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for advanced gastric cancer: experience from a Western tertiary referral center.
Rosa F; Galiandro F; Ricci R; Di Miceli D; Longo F; Quero G; Tortorelli AP; Alfieri S
Langenbecks Arch Surg; 2021 Sep; 406(6):1847-1857. PubMed ID: 33704561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
